Skip to content


Exjade, Jadenu, Jadenu Sprinkle (deferasirox) is a small molecule pharmaceutical. Deferasirox was first approved as Exjade on 2005-11-02. It is used to treat iron overload in the USA. It has been approved in Europe to treat beta-thalassemia and iron overload. Exjade's patent is valid until 2034-11-21 (FDA).
Trade Name Exjade
Common Name Deferasirox
Indication beta-thalassemia, iron overload
Drug Class
Get full access now